Capricor Therapeutics, Inc. (CAPR) vs Crescent Biopharma, Inc. (CBIO)
Capricor Therapeutics, Inc. and Crescent Biopharma, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and Crescent Biopharma, Inc. are of similar size ($528.9M and $508.7M). Capricor Therapeutics, Inc. grew revenue faster over the last twelve months: −11.6% against −45.1%. Across the 14 metrics below, Capricor Therapeutics, Inc. leads on 9 and Crescent Biopharma, Inc. on 5.
Valuation
Profitability
| Metric | CAPR | CBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 19.72% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (73.70%) | (112.14%) | (57.72%) |
| Return on assets | (51.53%) | (97.08%) | (49.22%) |
| Return on invested capital | (1,019.73%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack